{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:29:55Z","timestamp":1787009395471,"version":"build-2736575974"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,4,1]]},"DOI":"10.1093\/ndt\/15.4.524","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T18:37:35Z","timestamp":1027708655000},"page":"524-528","source":"Crossref","is-referenced-by-count":29,"title":["Treatment with different doses of folic acid in haemodialysis patients: effects on folate distribution and aminothiol concentrations"],"prefix":"10.1093","volume":"15","author":[{"given":"Margret","family":"Arnadottir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilmundur","family":"Gudnason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Hultberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2000,4]]},"reference":[{"key":"key\n\t\t\t\t20180202110729_R1","doi-asserted-by":"crossref","unstructured":"Stampfer MJ, Malinow MR, Willett WC et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. J Am Med Assoc1992; 268: 877\u2013881","DOI":"10.1001\/jama.268.7.877"},{"key":"key\n\t\t\t\t20180202110729_R2","doi-asserted-by":"crossref","unstructured":"Nyg\u00e5rd O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med1997; 337: 230\u2013236","DOI":"10.1056\/NEJM199707243370403"},{"key":"key\n\t\t\t\t20180202110729_R3","doi-asserted-by":"crossref","unstructured":"Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. J Am Med Assoc1995; 274: 1049\u20131057","DOI":"10.1001\/jama.274.13.1049"},{"key":"key\n\t\t\t\t20180202110729_R4","doi-asserted-by":"crossref","unstructured":"Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation1997; 95: 119\u2013121","DOI":"10.1161\/01.CIR.95.5.1119"},{"key":"key\n\t\t\t\t20180202110729_R5","doi-asserted-by":"crossref","unstructured":"Rodgers GM, Conn MT. Homocysteine, an atherogenic stimulus, reduced protein-C activation by arterial and venous endothelial cell. Blood1990; 75: 895\u2013901","DOI":"10.1182\/blood.V75.4.895.bloodjournal754895"},{"key":"key\n\t\t\t\t20180202110729_R6","unstructured":"Ueland PM, Refsum H, Brattstr\u00f6m L. Plasma homocysteine and cardiovascular disease. In: Francis RB Jr, ed. Atherosclerotic Cardiovascular Disease, Hemostasis, and Endothelial Function. Marcel Dekker Inc, New York, 1992; 183\u2013235"},{"key":"key\n\t\t\t\t20180202110729_R7","doi-asserted-by":"crossref","unstructured":"Homocysteine Lowering Trialist's Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Br Med J1998; 318: 894\u2013898","DOI":"10.1136\/bmj.316.7135.894"},{"key":"key\n\t\t\t\t20180202110729_R8","doi-asserted-by":"crossref","unstructured":"Stampfer MJ, Rimm EB. Folate and cardiovascular disease: why we need a trial now. J Am Med Assoc1996; 275: 1929\u20131930","DOI":"10.1001\/jama.275.24.1929"},{"key":"key\n\t\t\t\t20180202110729_R9","unstructured":"Dennis VW, Robinson K. Homocysteinemia and vascular disease in end-stage renal disease. Kidney Int1996; 50: S11\u201317"},{"key":"key\n\t\t\t\t20180202110729_R10","unstructured":"Raine AEG, Margreiter R, Brunner FP et al. Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant1992; 7 [Suppl. 2]: 7\u201335"},{"key":"key\n\t\t\t\t20180202110729_R11","unstructured":"Arnadottir M, Brattstr\u00f6m LE, Simonsen O et al. The effect of high-dose pyridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients. Clin Nephrol1993; 40: 236\u2013240"},{"key":"key\n\t\t\t\t20180202110729_R12","doi-asserted-by":"crossref","unstructured":"Bostom AG, Shemin D, Lapane KL et al. High-dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients. Kidney Int1996; 49: 147\u2013152","DOI":"10.1038\/ki.1996.19"},{"key":"key\n\t\t\t\t20180202110729_R13","unstructured":"Chauveau P, Chadefaux B, Coude M, Aupetit J, Kamoun P, Jungers P. Long-term folic acid (but not pyridoxine) supplementation lowers elevated plasma homocysteine level in chronic renal failure. Miner Electrolyte Metab1996; 22: 106\u2013109"},{"key":"key\n\t\t\t\t20180202110729_R14","doi-asserted-by":"crossref","unstructured":"van Guldener C, Jansen MJFM, Lambert J et al. No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in haemodialysis patients. Nephrol Dial Transplant1998; 13: 106\u2013112","DOI":"10.1093\/ndt\/13.1.106"},{"key":"key\n\t\t\t\t20180202110729_R15","unstructured":"Dierkes J, Domr\u00f6se U, Ambrosch A, Bosselmann HP, Neumann KH, Luley C. Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease. Clin Nephrol1999; 51: 108\u2013115"},{"key":"key\n\t\t\t\t20180202110729_R16","doi-asserted-by":"crossref","unstructured":"Hultberg B, Andersson A, Arnadottir M. Reduced, free and total fractions of homocysteine and other thiol compounds in plasma from patients with renal failure. Nephron1995; 70: 62\u201367","DOI":"10.1159\/000188545"},{"key":"key\n\t\t\t\t20180202110729_R17","doi-asserted-by":"crossref","unstructured":"Suliman ME, Anderstam B, Lindholm B, Bergstr\u00f6m J. Total, free, and protein-bound sulphur amino acids in uraemic patients. Nephrol Dial Transplant1997; 12: 2332\u20132338","DOI":"10.1093\/ndt\/12.11.2332"},{"key":"key\n\t\t\t\t20180202110729_R18","unstructured":"Jacobsson S, Moldeus P. Whole blood-, plasma- and red blood cell glutathione and cysteine in patients with kidney disease and during hemodialysis. Clin Nephol1994; 42: 189\u2013192"},{"key":"key\n\t\t\t\t20180202110729_R19","doi-asserted-by":"crossref","unstructured":"Andersson A, Isaksson A, Brattstr\u00f6m L, Hultberg H. Determination of homocysteine and other thiols in human plasma by high-performance liquid chromatography and a thiol-specific postcolumn derivatization procedure. Clin Chem1993; 39: 1590\u20131597","DOI":"10.1093\/clinchem\/39.8.1590"},{"key":"key\n\t\t\t\t20180202110729_R20","doi-asserted-by":"crossref","unstructured":"Goyette P, Sumner JS, Milos R et al. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nature Genet1994; 7: 195\u2013200","DOI":"10.1038\/ng0694-195"},{"key":"key\n\t\t\t\t20180202110729_R21","doi-asserted-by":"crossref","unstructured":"Wilcken DEL, Gupta VJ, Betts AK. Homocysteine in the plasma of renal transplant recipients: effects of cofactors for methionine metabolism. Clin Sci1981; 61: 743\u2013749","DOI":"10.1042\/cs0610743"},{"key":"key\n\t\t\t\t20180202110729_R22","doi-asserted-by":"crossref","unstructured":"Bostom AG, Shemin D, Nadeau MR et al. Short-term betaine therapy fails to lower elevated fasting total plasma homocysteine levels in hemodialysis patients maintained on chronic folic acid supplementation. Atherosclerosis1995; 113: 129\u2013132","DOI":"10.1016\/0021-9150(94)05466-V"},{"key":"key\n\t\t\t\t20180202110729_R23","doi-asserted-by":"crossref","unstructured":"Bostom AG, Shemin D, Lapane KL et al. Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis. Atherosclerosis1995; 114: 93\u2013103","DOI":"10.1016\/0021-9150(94)05470-4"},{"key":"key\n\t\t\t\t20180202110729_R24","doi-asserted-by":"crossref","unstructured":"Ladjimi H, Gounelle J, Auchere D. Effect of diet on folates levels and distribution in selected tissues in the rat. Arch Int Physiol Biochim Biophys1992; 100: 67\u201372","DOI":"10.3109\/13813459209035261"},{"key":"key\n\t\t\t\t20180202110729_R25","doi-asserted-by":"crossref","unstructured":"Perna AF, Ingrosso D, De Santo NG, Galletti P, Brunone M, Zappia V. Metabolic consequences of folate-induced reduction of hyperhomocysteinemia in uremia. J Am Soc Nephrol1997; 8: 1899\u20131905","DOI":"10.1681\/ASN.V8121899"},{"key":"key\n\t\t\t\t20180202110729_R26","doi-asserted-by":"crossref","unstructured":"F\u00f6dinger M, Mannhalter C, W\u00f6lfl G et al. Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients. Kidney Int1997; 52: 517\u2013523","DOI":"10.1038\/ki.1997.362"},{"key":"key\n\t\t\t\t20180202110729_R27","doi-asserted-by":"crossref","unstructured":"Van Guldener C, Jansen MJFM, de Meer K, Donker AJM, Stehouwer CDA. Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic hemodialysis patients. J Intern Med1999; 245: 175\u2013183","DOI":"10.1046\/j.1365-2796.1999.00430.x"},{"key":"key\n\t\t\t\t20180202110729_R28","doi-asserted-by":"crossref","unstructured":"Meister A. Glutathione metabolism and its selective modification. J Biol Chem1988; 263: 17205\u201317208","DOI":"10.1016\/S0021-9258(19)77815-6"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/15\/4\/524\/23763993\/150524.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T12:36:01Z","timestamp":1621254961000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/15\/4\/524\/1906382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4,1]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2000,4]]},"published-print":{"date-parts":[[2000,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/15.4.524","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published-other":{"date-parts":[[2000,4]]},"published":{"date-parts":[[2000,4,1]]}}}